{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T08:53:21Z","timestamp":1785401601239,"version":"3.56.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thoracic.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thoracic Surgery Clinics"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.thorsurg.2025.09.006","type":"journal-article","created":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T02:22:36Z","timestamp":1759544556000},"page":"115-122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Role of Surgery for Patients with Metastatic Non-small Cell Lung Cancer"],"prefix":"10.1016","volume":"36","author":[{"given":"Mariya L.","family":"Samoylova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula Duarte","family":"D\u2019Ambrosio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle G.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara B.","family":"Antonoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.thorsurg.2025.09.006_bib1","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.lungcan.2014.12.006","article-title":"Longitudinal analysis of 2293 NSCLC patients: a comprehensive study from the TYROL registry","volume":"87","author":"Kocher","year":"2015","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1016\/j.thorsurg.2025.09.006_bib2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/JTO.0b013e3181c5920c","article-title":"Trends in stage distribution for patients with non-small cell lung cancer: a National Cancer Database survey","volume":"5","author":"Morgensztern","year":"2010","journal-title":"J Thorac Oncol"},{"issue":"28","key":"10.1016\/j.thorsurg.2025.09.006_bib3","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.1200\/JCO.2008.17.7162","article-title":"Chemotherapy in addition to supportive care improves survival in advanced non-small-cell lung cancer: a systematic review and meta-analysis of individual patient data from 16 randomized controlled trials","volume":"26","year":"2008","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.thorsurg.2025.09.006_bib5","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1200\/JCO.18.00149","article-title":"Updated analysis of KEYNOTE-024: Pembrolizumab versus Platinum-based chemotherapy for advanced non-small-cell lung cancer with PD-L1 tumor proportion score of 50% or greater","volume":"37","author":"Reck","year":"2019","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.thorsurg.2025.09.006_bib6","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/jso.27165","article-title":"The \u201cnew\u201d oligometastatic disease state and associated therapies in non-small cell lung cancer: a narrative review","volume":"127","author":"Na","year":"2023","journal-title":"J Surg Oncol"},{"issue":"1","key":"10.1016\/j.thorsurg.2025.09.006_bib7","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1200\/JCO.1995.13.1.8","article-title":"Oligometastases","volume":"13","author":"Hellman","year":"1995","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.thorsurg.2025.09.006_bib8","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/ncponc0075","article-title":"Importance of local control in an era of systemic therapy","volume":"2","author":"Hellman","year":"2005","journal-title":"Nat Clin Pract Oncol"},{"issue":"2","key":"10.1016\/j.thorsurg.2025.09.006_bib9","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jtcvs.2023.09.048","article-title":"Surgery for oligometastatic non-small cell lung cancer","volume":"167","author":"Antonoff","year":"2024","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"12","key":"10.1016\/j.thorsurg.2025.09.006_bib10","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/S1470-2045(16)30532-0","article-title":"Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study","volume":"17","author":"Gomez","year":"2016","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.thorsurg.2025.09.006_bib11","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2017.3501","article-title":"Consolidative radiotherapy for limited metastatic non-small-cell lung cancer: a phase 2 randomized clinical trial","volume":"4","author":"Iyengar","year":"2018","journal-title":"JAMA Oncol"},{"issue":"6","key":"10.1016\/j.thorsurg.2025.09.006_bib12","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/jnci\/djac015","article-title":"Randomized trial of first-line tyrosine kinase inhibitor with or without radiotherapy for synchronous oligometastatic EGFR-mutated non-small cell lung cancer","volume":"115","author":"Wang","year":"2023","journal-title":"J Natl Cancer Inst"},{"issue":"18","key":"10.1016\/j.thorsurg.2025.09.006_bib13","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1200\/JCO.19.00201","article-title":"Local consolidative therapy vs. maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer: long-term results of a multi-institutional, phase II, randomized study","volume":"37","author":"Gomez","year":"2019","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.thorsurg.2025.09.006_bib14","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cllc.2019.07.007","article-title":"Improved overall survival with comprehensive local consolidative therapy in synchronous oligometastatic non-small-cell lung cancer","volume":"21","author":"Mitchell","year":"2020","journal-title":"Clin Lung Cancer"},{"issue":"3","key":"10.1016\/j.thorsurg.2025.09.006_bib15","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.lungcan.2010.05.003","article-title":"Surgical treatment of oligometastatic non-small cell lung cancer","volume":"69","author":"Pfannschmidt","year":"2010","journal-title":"Lung Cancer Amst Neth"},{"issue":"11","key":"10.1016\/j.thorsurg.2025.09.006_bib16","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/j.jtho.2017.08.008","article-title":"The role of thoracic surgery in the therapeutic management of metastatic non-small cell lung cancer","volume":"12","author":"David","year":"2017","journal-title":"J Thorac Oncol"},{"issue":"2","key":"10.1016\/j.thorsurg.2025.09.006_bib17","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ijrobp.2019.10.038","article-title":"Immune and circulating tumor DNA profiling after radiation treatment for oligometastatic non-small cell lung cancer: translational correlatives from a mature randomized phase II trial","volume":"106","author":"Tang","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"25","key":"10.1016\/j.thorsurg.2025.09.006_bib18","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1200\/JCO.20.00818","article-title":"Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: long-term results of the SABR-COMET Phase II Randomized Trial","volume":"38","author":"Palma","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.thorsurg.2025.09.006_bib19","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.lungcan.2017.11.021","article-title":"Long-term outcomes of surgical resection for stage IV non-small-cell lung cancer: a national analysis","volume":"115","author":"Yang","year":"2018","journal-title":"Lung Cancer Amst Neth"},{"issue":"4","key":"10.1016\/j.thorsurg.2025.09.006_bib20","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.jtcvs.2020.02.134","article-title":"Pulmonary resection is associated with long-term survival and should remain a therapeutic option in oligometastatic lung cancer","volume":"161","author":"Mitchell","year":"2021","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"2","key":"10.1016\/j.thorsurg.2025.09.006_bib21","doi-asserted-by":"crossref","first-page":"310","DOI":"10.21037\/jtd.2017.02.21","article-title":"Should aggressive thoracic therapy be performed in patients with synchronous oligometastatic non-small cell lung cancer? A meta-analysis","volume":"9","author":"Li","year":"2017","journal-title":"J Thorac Dis"},{"issue":"2","key":"10.1016\/j.thorsurg.2025.09.006_bib22","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.jtcvs.2017.03.142","article-title":"Salvage pulmonary resection after stereotactic body radiotherapy: a feasible and safe option for local failure in selected patients","volume":"154","author":"Antonoff","year":"2017","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"22","key":"10.1016\/j.thorsurg.2025.09.006_bib23","doi-asserted-by":"crossref","first-page":"5735","DOI":"10.1158\/1078-0432.CCR-17-3279","article-title":"Radiation Followed by OX40 stimulation drives local and abscopal antitumor effects in an anti-PD1-resistant lung tumor model","volume":"24","author":"Niknam","year":"2018","journal-title":"Clin Cancer Res"},{"issue":"8","key":"10.1016\/j.thorsurg.2025.09.006_bib25","doi-asserted-by":"crossref","first-page":"4688","DOI":"10.1245\/s10434-022-11627-9","article-title":"Osimertinib, surgery, and radiation therapy in treating patients with stage IIIB or IV Non-Small Cell Lung Cancer with EGFR Mutations (NORTHSTAR)","volume":"29","author":"Khan","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"10.1016\/j.thorsurg.2025.09.006_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtho.2018.08.1754","article-title":"P3.08-04 OMEGA, a randomized trial of local ablative therapy vs. conventional treatment in oligometastatic NSCLC \u2013 trial in Progress","volume":"13","author":"Infante","year":"2018","journal-title":"J Thorac Oncol"},{"issue":"6","key":"10.1016\/j.thorsurg.2025.09.006_bib27","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/j.jtcvs.2023.08.024","article-title":"Perioperative and oncologic outcomes of pulmonary resection for synchronous oligometastatic non-small cell lung cancer: evidence for surgery in advanced disease","volume":"167","author":"Deboever","year":"2024","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"2","key":"10.1016\/j.thorsurg.2025.09.006_bib29","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jtcvs.2012.05.051","article-title":"Surgery for oligometastatic non-small cell lung cancer: long-term results from a single center experience","volume":"144","author":"Congedo","year":"2012","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"3","key":"10.1016\/j.thorsurg.2025.09.006_bib30","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.21037\/tlcr-21-39","article-title":"Surgery for advanced-stage non-small cell lung cancer: lobectomy or sub-lobar resection?","volume":"10","author":"Hao","year":"2021","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.thorsurg.2025.09.006_bib31","article-title":"Lobectomy can improve the survival of patients with non-small cell lung cancer with lung oligometastatic","volume":"8","author":"Wang","year":"2021","journal-title":"Front Surg"},{"key":"10.1016\/j.thorsurg.2025.09.006_bib32","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.lungcan.2021.02.001","article-title":"A risk stratification scheme for synchronous oligometastatic non-small cell lung cancer developed by a multicentre analysis","volume":"154","author":"Spaggiari","year":"2021","journal-title":"Lung Cancer"},{"issue":"3","key":"10.1016\/j.thorsurg.2025.09.006_bib33","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.athoracsur.2024.11.010","article-title":"The Society of Thoracic Surgeons (STS) clinical practice guideline on surgical management of oligometastatic non-small cell lung cancer","volume":"119","author":"Antonoff","year":"2025","journal-title":"Ann Thorac Surg"},{"issue":"9","key":"10.1016\/j.thorsurg.2025.09.006_bib34","doi-asserted-by":"crossref","first-page":"775","DOI":"10.21037\/atm-21-540","article-title":"Surgical resection of primary tumors improved the prognosis of patients with bone metastasis of non-small cell lung cancer: a population-based and propensity score-matched study","volume":"9","author":"Tian","year":"2021","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.thorsurg.2025.09.006_bib35","article-title":"Local therapy treatment conditions for oligometastatic non-small cell lung cancer","volume":"12","author":"Zhang","year":"2022","journal-title":"Front Oncol"},{"issue":"10","key":"10.1016\/j.thorsurg.2025.09.006_bib36","doi-asserted-by":"crossref","first-page":"5942","DOI":"10.21037\/jtd-21-997","article-title":"Prognostic value of surgical intervention in advanced lung adenocarcinoma: a population-based study","volume":"13","author":"Zhu","year":"2021","journal-title":"J Thorac Dis"},{"issue":"6","key":"10.1016\/j.thorsurg.2025.09.006_bib37","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1093\/ejcts\/ezz384","article-title":"Prognostic factors of oligometastatic non-small-cell lung cancer following radical therapy: a multicentre analysis","volume":"57","author":"Opitz","year":"2020","journal-title":"Eur J Cardiothorac Surg"},{"issue":"12","key":"10.1016\/j.thorsurg.2025.09.006_bib38","doi-asserted-by":"crossref","first-page":"5463","DOI":"10.21037\/jtd.2019.11.30","article-title":"Surgical outcomes of stage IV non-small cell lung cancer: a single-center experience","volume":"11","author":"Zhang","year":"2019","journal-title":"J Thorac Dis"},{"issue":"3","key":"10.1016\/j.thorsurg.2025.09.006_bib39","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1067\/mtc.2001.116201","article-title":"Surgical treatment of primary lung cancer with synchronous brain metastases","volume":"122","author":"Billing","year":"2001","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"5","key":"10.1016\/j.thorsurg.2025.09.006_bib40","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.cllc.2014.04.003","article-title":"An individual patient data metaanalysis of outcomes and prognostic factors after treatment of oligometastatic non-small-cell lung cancer","volume":"15","author":"Ashworth","year":"2014","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.thorsurg.2025.09.006_bib42","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.radonc.2020.04.003","article-title":"Defining oligometastatic disease from a radiation oncology perspective: an ESTRO-ASTRO consensus document","volume":"148","author":"Lievens","year":"2020","journal-title":"Radiother Oncol J Eur Soc Ther Radiol Oncol"},{"issue":"4","key":"10.1016\/j.thorsurg.2025.09.006_bib43","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1097\/JS9.0000000000000339","article-title":"Role of local ablative treatment in oligometastatic non-small cell lung cancer: a meta-analysis","volume":"109","author":"Rim","year":"2023","journal-title":"Int J Surg Lond Engl"},{"key":"10.1016\/j.thorsurg.2025.09.006_bib44","article-title":"Progression patterns, treatment, and prognosis beyond resistance of responders to immunotherapy in advanced non-small cell lung cancer","volume":"11","author":"Xu","year":"2021","journal-title":"Front Oncol"},{"issue":"10422","key":"10.1016\/j.thorsurg.2025.09.006_bib45","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0140-6736(23)01857-3","volume":"403","author":"Tsai","year":"2024","journal-title":"Lancet Lond Engl"},{"issue":"4","key":"10.1016\/j.thorsurg.2025.09.006_bib48","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.annonc.2022.12.009","article-title":"Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"34","author":"Hendriks","year":"2023","journal-title":"Ann Oncol"},{"key":"10.1016\/j.thorsurg.2025.09.006_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtcvs.2025.03.029","article-title":"Timing of local consolidative pulmonary resection for oncogene-driven stage IV lung cancer","author":"Antonoff","year":"2025","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"15_suppl","key":"10.1016\/j.thorsurg.2025.09.006_bib50","doi-asserted-by":"crossref","first-page":"9624","DOI":"10.1200\/JCO.2020.38.15_suppl.9624","article-title":"BRIGHTSTAR: a pilot trial of local consolidative therapy (LCT) with brigatinib in tyrosine kinase inhibitor (TKI)-na\u00efve ALK-rearranged advanced NSCLC","volume":"38","author":"Elamin","year":"2020","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.thorsurg.2025.09.006_bib51","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0360-3016(98)00442-8","article-title":"Identification of prognostic factors in patients with brain metastases: a review of 1292 patients","volume":"43","author":"Lagerwaard","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.thorsurg.2025.09.006_bib53","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ccell.2023.12.013","article-title":"Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancer","volume":"42","author":"Memon","year":"2024","journal-title":"Cancer Cell"},{"issue":"133","key":"10.1016\/j.thorsurg.2025.09.006_bib54","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1183\/09059180.00004614","article-title":"Molecular mechanisms of resistance in epidermal growth factor receptor-mutant lung adenocarcinomas","volume":"23","author":"Cortot","year":"2014","journal-title":"Eur Respir Rev"},{"issue":"1","key":"10.1016\/j.thorsurg.2025.09.006_bib55","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-22957-9","article-title":"The surgical resection of the primary tumor increases survival in patients with EGFR-mutant advanced non-small cell lung cancer: a tertiary center cohort study","volume":"12","author":"Chen","year":"2022","journal-title":"Sci Rep"},{"issue":"16_suppl","key":"10.1016\/j.thorsurg.2025.09.006_bib56","doi-asserted-by":"crossref","first-page":"8506","DOI":"10.1200\/JCO.2024.42.16_suppl.8506","article-title":"NRG-LU002: randomized phase II\/III trial of maintenance systemic therapy versus local consolidative therapy (LCT) plus maintenance systemic therapy for limited metastatic non-small cell lung cancer (NSCLC)","volume":"42","author":"Iyengar","year":"2024","journal-title":"J Clin Oncol"}],"container-title":["Thoracic Surgery Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547412725000763?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547412725000763?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T23:38:11Z","timestamp":1763768291000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547412725000763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1547412725000763"],"URL":"https:\/\/doi.org\/10.1016\/j.thorsurg.2025.09.006","relation":{},"ISSN":["1547-4127"],"issn-type":[{"value":"1547-4127","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of Surgery for Patients with Metastatic Non-small Cell Lung Cancer","name":"articletitle","label":"Article Title"},{"value":"Thoracic Surgery Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thorsurg.2025.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}